Brief: Cumberland Pharmaceuticals Reports Q4 Adj Earnings Per Share Of $0.01
March 9 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS 9% REVENUE GROWTH IN
2020
* Q4 REVENUE ROSE 10 PERCENT TO $10.3 MILLION
* Q4 ADJUSTED EARNINGS PER SHARE $0.01
* QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.12
* QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nPn1r2Hhza
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM